Skip to content
Quest Training

Health Technology Assessment & Economic Evaluation Training Course

Equips formulary committees, payers and market-access teams to appraise clinical evidence, cost-effectiveness and budget impact for coverage decisions.

PMS · Pharmaceutical & Medical Supply ManagementAll Levels#3010ClassroomEnglish , Arabic
Duration
5 Days
Download BrochureView Upcoming Dates

Free substitution at any time · 30+ days' notice: full refund minus 10%. Cancellation policy

Sectors:Healthcare & Hospital ManagementCategories:Pharmaceutical & Medical Supply Management

Course Overview

This practical course provides a structured framework for health technology assessment (HTA) and health economic evaluation as tools for evidence-informed formulary, coverage, and purchasing decisions. It focuses on how ministries, payers, hospitals, and pharmaceutical companies judge whether a new medicine, device, or program offers value for money within a limited budget. The program examines HTA processes and governance, decision-problem scoping, appraisal of clinical and real-world evidence, cost-effectiveness and cost-utility analysis, decision modeling, uncertainty analysis, and budget impact analysis. It also covers how findings are translated into recommendations, pricing negotiations, and managed entry agreements. Participants will develop the ability to read and challenge economic submissions, interpret incremental cost-effectiveness ratios and quality-adjusted life years, test model assumptions, and estimate affordability. Particular attention is given to transparency, stakeholder input, and consistency of decision criteria. Through evidence appraisal exercises, simplified models, committee simulations, and case studies, participants will strengthen their ability to prepare, review, and act on health technology assessments with confidence.

Learning Objectives

  • Explain the purpose, scope, and governance of health technology assessment in coverage decisions.
  • Define the decision problem and assessment scope using structured frameworks.
  • Appraise the quality, relevance, and certainty of clinical evidence for decision-making.
  • Interpret systematic reviews, meta-analyses, and indirect treatment comparisons.
  • Evaluate the role and limitations of real-world evidence in assessments.
  • Distinguish the main types of economic evaluation and their appropriate use.
  • Identify, measure, and value costs and health outcomes from a defined perspective.
  • Interpret quality-adjusted life years, incremental cost-effectiveness ratios, and decision thresholds.
  • Review the structure, inputs, and assumptions of decision-analytic models.
  • Apply sensitivity and scenario analysis to characterize decision uncertainty.
  • Estimate the affordability of new technologies through budget impact analysis.
  • Translate assessment findings into formulary, pricing, and managed entry recommendations.

Who Should Attend

This program is designed for formulary and pharmacy and therapeutics committee members, health technology assessment officers, payer and purchasing managers, insurance benefit managers, and reimbursement specialists. It is also suitable for pharmaceutical and medical device professionals in market access, health economics, pricing, and medical affairs who prepare value dossiers and economic submissions. The program is particularly relevant to professionals in ministries of health, regulatory and pricing authorities, public and private insurers, hospital groups, procurement agencies, and pharmaceutical companies responsible for coverage, pricing, and resource-allocation decisions.

Learning Outcomes

  • Describe how health technology assessment supports value-based coverage and purchasing decisions.
  • Formulate a clear decision problem for assessing a medicine, device, or program.
  • Critically appraise clinical trial evidence and summarize its certainty for a committee.
  • Judge the suitability of indirect comparisons and real-world data for local decisions.
  • Select an appropriate economic evaluation method for a given decision.
  • Calculate and interpret incremental cost-effectiveness ratios and dominance.
  • Assess the transparency and quality of economic submissions against reporting standards.
  • Identify the key assumptions driving the results of a decision model.
  • Interpret deterministic and probabilistic sensitivity analysis results.
  • Prepare a budget impact estimate that reflects local population and uptake.
  • Draft evidence-based recommendations, listing conditions, and managed entry options.
  • Contribute to stronger HTA processes and governance within their organization.

Course Outline

Day 1

Health Technology Assessment Foundations & Decision Frameworks

  • Purpose and scope of health technology assessment
  • Technologies assessed: medicines, devices, diagnostics, and programs
  • Value-based healthcare and resource allocation
  • HTA institutional models and governance arrangements
  • Links between HTA, registration, pricing, and reimbursement
  • Decision criteria: added benefit, cost, affordability, and unmet need
  • Scoping the decision problem with the PICO framework
  • Stakeholder roles and evidence submission processes
  • Transparency, conflicts of interest, and appeal mechanisms
  • Practical Application: Scope an assessment and define the decision problem for a new medicine
Day 2

Clinical Evidence Appraisal for Coverage Decisions

  • Hierarchy and sources of clinical evidence
  • Systematic reviews and evidence synthesis
  • Critical appraisal of randomized controlled trials
  • Relevant outcomes, surrogate endpoints, and effect sizes
  • Principles of meta-analysis and network meta-analysis
  • Indirect treatment comparisons when head-to-head data are absent
  • Real-world evidence, registries, and observational data
  • Risk of bias and certainty of the evidence
  • Applicability of evidence to the local population
  • Practical Application: Appraise an evidence package and summarize its strengths and gaps for a committee
Day 3

Economic Evaluation Methods & Cost-Effectiveness Analysis

  • Principles of health economic evaluation
  • Cost-minimization, cost-effectiveness, cost-utility, and cost-benefit analysis
  • Perspective, time horizon, and discounting
  • Identifying, measuring, and valuing costs
  • Health outcomes, utilities, and quality-adjusted life years
  • Incremental cost-effectiveness ratios and dominance
  • Willingness-to-pay thresholds and decision rules
  • Reporting standards and the CHEERS checklist
  • Reviewing manufacturer economic submissions
  • Practical Application: Calculate and interpret incremental cost-effectiveness ratios for competing alternatives
Day 4

Decision Modeling, Uncertainty & Budget Impact Analysis

  • Role of decision-analytic models in assessment
  • Decision tree models and their applications
  • Markov and state-transition models
  • Sourcing, validating, and documenting model inputs
  • Deterministic and probabilistic sensitivity analysis
  • Scenario analysis and value of information concepts
  • Budget impact analysis structure and eligible population estimates
  • Market uptake, displacement, and affordability
  • Presenting uncertainty clearly to decision-makers
  • Practical Application: Build a simplified budget impact model and test its key assumptions
Day 5

From Assessment to Formulary, Pricing & Managed Entry

  • Writing assessment reports and recommendations
  • Committee deliberation and multi-criteria decision analysis
  • Formulary listing, restrictions, and conditions of use
  • Price negotiation informed by economic evidence
  • Financial and outcome-based managed entry agreements
  • Reassessment and disinvestment of existing technologies
  • Monitoring implementation and real-world performance
  • Building national and institutional HTA capacity
  • Communicating decisions to clinicians, patients, and the public
  • Practical Application: Simulate a formulary committee decision and draft a managed entry proposal

Upcoming Dates

Selected date

Kuala Lumpur · 4 – 8 Oct 2027 · Classroom

Need more details?Chat with us on WhatsApp

CityDatesPrice per ParticipantEarly Bird
DohaScheduled
8 – 12 Nov 2026€4,400—
SelectDownload Brochure
DubaiScheduled
8 – 12 Nov 2026€4,400—
SelectDownload Brochure
ErbilScheduled
15 – 19 Nov 2026€3,100—
SelectDownload Brochure
FrankfurtScheduled
23 – 27 Nov 2026€5,800—
SelectDownload Brochure
GenevaScheduled
23 – 27 Nov 2026€6,300—
SelectDownload Brochure
IstanbulScheduled
30 Nov – 4 Dec 2026€4,700€4,230until 9 Nov
SelectDownload Brochure
JeddahScheduled
6 – 10 Dec 2026€4,200€3,780until 16 Nov
SelectDownload Brochure
KigaliScheduled
7 – 11 Dec 2026€5,100€4,590until 16 Nov
SelectDownload Brochure
Kuala LumpurScheduled
14 – 18 Dec 2026€4,400€3,960until 23 Nov
SelectDownload Brochure
LisbonScheduled
21 – 25 Dec 2026€5,400€4,860until 30 Nov
SelectDownload Brochure
LondonScheduled
28 Dec 2026 – 1 Jan 2027€5,600€5,040until 7 Dec
SelectDownload Brochure
MadinahScheduled
28 Dec 2026 – 1 Jan 2027€4,200€3,780until 7 Dec
SelectDownload Brochure
MadridScheduled
4 – 8 Jan 2027€5,400€4,860until 14 Dec
SelectDownload Brochure
MakkahScheduled
11 – 15 Jan 2027€4,200€3,780until 21 Dec
SelectDownload Brochure
ManamaScheduled
11 – 15 Jan 2027€4,700€4,230until 21 Dec
SelectDownload Brochure
MuscatScheduled
18 – 22 Jan 2027€5,300€4,770until 28 Dec
SelectDownload Brochure
OnlineScheduled
24 – 28 Jan 2027€1,700€1,530until 4 Jan
SelectDownload Brochure
ParisScheduled
25 – 29 Jan 2027€5,700€5,130until 4 Jan
SelectDownload Brochure
SalalahScheduled
1 – 5 Feb 2027€5,300€4,770until 11 Jan
SelectDownload Brochure
AbujaScheduled
8 – 12 Feb 2027€5,100€4,590until 18 Jan
SelectDownload Brochure
AmmanScheduled
14 – 18 Feb 2027€3,100€2,790until 25 Jan
SelectDownload Brochure
AmsterdamScheduled
15 – 19 Feb 2027€5,400€4,860until 25 Jan
SelectDownload Brochure
BakuScheduled
22 – 26 Feb 2027€4,800€4,320until 1 Feb
SelectDownload Brochure
BangkokScheduled
1 – 5 Mar 2027€6,100€5,490until 8 Feb
SelectDownload Brochure
BarcelonaScheduled
1 – 5 Mar 2027€5,400€4,860until 8 Feb
SelectDownload Brochure
BeirutScheduled
7 – 11 Mar 2027€4,000€3,600until 15 Feb
SelectDownload Brochure
CairoScheduled
14 – 18 Mar 2027€3,300€2,970until 22 Feb
SelectDownload Brochure
Cape TownScheduled
15 – 19 Mar 2027€5,100€4,590until 22 Feb
SelectDownload Brochure
CasablancaScheduled
22 – 26 Mar 2027€4,300€3,870until 1 Mar
SelectDownload Brochure
DammamScheduled
28 Mar – 1 Apr 2027€4,200€3,780until 8 Mar
SelectDownload Brochure
Kuala LumpurScheduled
4 – 8 Oct 2027€4,400€3,960until 13 Sept
✓ SelectedDownload Brochure

Available in: Istanbul · Dubai · London · Doha · Amsterdam

Related Courses

Ready to Elevate Your Team's Capabilities?

Speak with our advisors about upcoming programmes or a bespoke corporate training plan.

Download BrochureContact Our Team